MD+DI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Home>Business

Top 10 Medtech Deals of Q2 (Neuronetics)

 No. 9 Name of Company: Neuronetics Inc. Headquarters: Malvern, Pennsylvania

 No. 9

Name of Company: Neuronetics Inc.

Headquarters: Malvern, Pennsylvania

Product: NeuroStar transcranial magnetic stimulation therapy, which treats patients with major depressive disorder with a form of neuromodulation.

Amount Raised: $34.3 million

Investors: Accuitive Medical Ventures, GE Ventures, InterWest Partners, Investor Growth Capital, New Leaf Venture Partners, ONSET Ventures, Polaris Venture Partners, Three Arch Partners, and an undisclosed firm.

             

Source: MoneyTree Report and Neuronetics
TAGS: News
Hide comments
account-default-image
user not logged in

More information about text formats

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish
Related
MDM West-Logo-SML-Transparent[1].jpg
Medical Design & Manufacturing (MD&M) West 2021
genotyping
Collaboration Puts a Diversity 'Twist' on Genotyping
Jun 14, 2021
KAM for Medtech
Key Account Management Is a Priority for Medtech Leaders
Jun 10, 2021
Covid-19 testing
Abbott Sees COVID-19 Testing Demand Droop as Restrictions Ease
Jun 07, 2021